Vc-backed IsoPlexis goes public
IsoPlexis, a provider of functional single-cell proteomics, has raised $125 million for its IPO after pricing its over 8.33 million shares at $15 per share.
IsoPlexis, a provider of functional single-cell proteomics, has raised $125 million for its IPO after pricing its over 8.33 million shares at $15 per share.
Copyright PEI Media
Not for publication, email or dissemination